Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome. [electronic resource]
Producer: 20091221Description: 1418-23 p. digitalISSN:- 1539-2864
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Choroidal Neovascularization -- diagnosis
- Eye Infections, Fungal -- complications
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Histoplasmosis -- complications
- Humans
- Injections
- Male
- Middle Aged
- Retreatment
- Retrospective Studies
- Syndrome
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
- Vitreous Body
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.